Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Salmeterol/Fluticasone vs Fluticasone Response to Rhinovirus in Asthma
NCT00503009Phase 4Terminated
- Sponsor
- GSK
- Start
- Oct 2007
- Primary completion
- Jul 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of salmeterol in asthma (3 arms), sponsored by GSK. Primary endpoint: Change From Baseline in the Cumulative Lower Respiratory Symptom Score Averaged Over Days 1-4. Started Oct 2007; status: terminated.
02
Drugs
salmeterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00503009.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00503009.